Nakagawa T - Search Results

1

Insulin-like growth factor 1: role in the auditory system and therapeutic potential in otology.

Gao L, Nakagawa T. Gao L, et al. Among authors: nakagawa t. Curr Opin Otolaryngol Head Neck Surg. 2020 Oct;28(5):286-290. doi: 10.1097/MOO.0000000000000652. Curr Opin Otolaryngol Head Neck Surg. 2020. PMID: 32796270 Review.

2

Cochlear protection by local insulin-like growth factor-1 application using biodegradable hydrogel.

Iwai K, Nakagawa T, Endo T, Matsuoka Y, Kita T, Kim TS, Tabata Y, Ito J. Iwai K, et al. Among authors: nakagawa t. Laryngoscope. 2006 Apr;116(4):529-33. doi: 10.1097/01.mlg.0000200791.77819.eb. Laryngoscope. 2006. PMID: 16585854

3

Novel therapy for hearing loss: delivery of insulin-like growth factor 1 to the cochlea using gelatin hydrogel.

Lee KY, Nakagawa T, Okano T, Hori R, Ono K, Tabata Y, Lee SH, Ito J. Lee KY, et al. Among authors: nakagawa t. Otol Neurotol. 2007 Oct;28(7):976-81. doi: 10.1097/MAO.0b013e31811f40db. Otol Neurotol. 2007. PMID: 17704706

4

Insulin-like growth factor 1 treatment via hydrogels rescues cochlear hair cells from ischemic injury.

Fujiwara T, Hato N, Nakagawa T, Tabata Y, Yoshida T, Komobuchi H, Takeda S, Hyodo J, Hakuba N, Gyo K. Fujiwara T, et al. Among authors: nakagawa t. Neuroreport. 2008 Oct 29;19(16):1585-8. doi: 10.1097/WNR.0b013e328311ca4b. Neuroreport. 2008. PMID: 18845939

5

Hepatocyte growth factor protects auditory hair cells from aminoglycosides.

Kikkawa YS, Nakagawa T, Tsubouchi H, Ido A, Inaoka T, Ono K, Ito J. Kikkawa YS, et al. Among authors: nakagawa t. Laryngoscope. 2009 Oct;119(10):2027-31. doi: 10.1002/lary.20602. Laryngoscope. 2009. PMID: 19688848

6

Role of prostaglandin E receptor subtypes EP2 and EP4 in autocrine and paracrine functions of vascular endothelial growth factor in the inner ear.

Hori R, Nakagawa T, Yamamoto N, Hamaguchi K, Ito J. Hori R, et al. Among authors: nakagawa t. BMC Neurosci. 2010 Mar 11;11:35. doi: 10.1186/1471-2202-11-35. BMC Neurosci. 2010. PMID: 20219142 Free PMC article.

7

Inner ear drug delivery system from the clinical point of view.

Sakamoto T, Nakagawa T, Horie RT, Hiraumi H, Yamamoto N, Kikkawa YS, Ito J. Sakamoto T, et al. Among authors: nakagawa t. Acta Otolaryngol Suppl. 2010 Nov;(563):101-4. doi: 10.3109/00016489.2010.486801. Acta Otolaryngol Suppl. 2010. PMID: 20879828 Clinical Trial.

8

Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: a prospective clinical trial.

Nakagawa T, Sakamoto T, Hiraumi H, Kikkawa YS, Yamamoto N, Hamaguchi K, Ono K, Yamamoto M, Tabata Y, Teramukai S, Tanaka S, Tada H, Onodera R, Yonezawa A, Inui K, Ito J. Nakagawa T, et al. BMC Med. 2010 Nov 25;8:76. doi: 10.1186/1741-7015-8-76. BMC Med. 2010. PMID: 21108784 Free PMC article.

9

Insulin-like growth factor 1 protects vestibular hair cells from aminoglycosides.

Angunsri N, Taura A, Nakagawa T, Hayashi Y, Kitajiri S, Omi E, Ishikawa K, Ito J. Angunsri N, et al. Among authors: nakagawa t. Neuroreport. 2011 Jan 5;22(1):38-43. doi: 10.1097/WNR.0b013e32834273e9. Neuroreport. 2011. PMID: 21127443

10

Audiometric outcomes of topical IGF1 treatment for sudden deafness refractory to systemic steroids.

Nakagawa T, Ogino-Nishimura E, Hiraumi H, Sakamoto T, Yamamoto N, Ito J. Nakagawa T, et al. Otol Neurotol. 2012 Aug;33(6):941-6. doi: 10.1097/MAO.0b013e31825f251a. Otol Neurotol. 2012. PMID: 22772021 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,276 results

Search Page